Delivery Order SPE2DB22D1103-SPE2DB25FTMD1

Award Date 5/7/25
Potential Completion Date 5/8/25
Potential Value $9.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,854.95, is for the delivery of CIMZIA 2X200 MG/ML syringe kits, a medication used to treat certain medical conditions. The contract has a firm fixed price and an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,039,841 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS, with a firm fixed price ceiling value of $4,831.52. The contract has an ultimate completion date of April 28, 2025 and was awarded on April 25, 2025. This delivery order is part of a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,123,197 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS, with a ceiling value of $27,118.73 and a period of performance through May 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $20,933.77, is for the delivery of 4,567,942,222 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS. The contract is a firm fixed-price delivery order with an ultimate completion date of April 17, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,942,875 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS, with a ceiling value of $3,911.81. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. The ultimate completion date for this order is April 17, 2025. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,830.41, is for the delivery of 4,568,119,270 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS. The contract is a firm fixed-price, non-set-aside award with a completion date of May 5, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,851.85 firm-fixed-price contract is for the provision of CIMZIA 2X200 MG/ML syringe kits. This order is under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,673,289 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS. The contract has a ceiling value of $30,763.22 and a period of performance through March 24, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a $8,858.37 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4567857284 - CIMZIA 2X200 MG/ML SYRINGE KITS. The contract has an ultimate completion date of April 10, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CIMZIA 2X200 MG/ML syringe kits, with a ceiling value of $9,738.88 and a completion date of December 15, 2023. This award is under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTMD1
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,924.83, is for the delivery of 4,568,171,146 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS. The contract is a firm-fixed price arrangement with a performance period ending on May 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set-aside and was awarded through open competition.

Generated 8/6/25, 10:02 AM